A scientist transfers fluids into a tube at the Driver Inc. laboratory in Shantou, China, on Wednesday, August 29, 2018. A pair of Harvard-trained American oncologists behind the startup Driver, backed by Hong Kong billionaire†Li Ka-shing, are attempting to harness technology to revamp cancer care. They're taking some of their earliest steps in China -- cancer's ground zero. Photo: Bloomberg

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?

  • Nearly a quarter of the world’s newly diagnosed cancer cases in 2015 were in China
  • Lung cancer tops the list of China’s tumours, with the number of cases expected to grow by 40 per cent to 1.26 million by 2030
Topic |   Pharmaceuticals

TOP PICKS

A scientist transfers fluids into a tube at the Driver Inc. laboratory in Shantou, China, on Wednesday, August 29, 2018. A pair of Harvard-trained American oncologists behind the startup Driver, backed by Hong Kong billionaire†Li Ka-shing, are attempting to harness technology to revamp cancer care. They're taking some of their earliest steps in China -- cancer's ground zero. Photo: Bloomberg
READ FULL ARTICLE